Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease
- PMID: 26789999
- DOI: 10.1159/000441768
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease
Erratum in
-
Erratum.Digestion. 2016;93(2):174. doi: 10.1159/000444541. Epub 2016 Mar 3. Digestion. 2016. PMID: 26937651
Abstract
Background: The global alteration of the gut microbial community (dysbiosis) plays an important role in the pathogenesis of inflammatory bowel diseases (IBDs). However, bacterial species that characterize dysbiosis in IBD remain unclear. In this study, we assessed the alteration of the fecal microbiota profile in patients with Crohn's disease (CD) using 16S rRNA sequencing.
Summary: Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing. The V3-V4 hypervariable regions of 16S rRNA were sequenced by the Illumina MiSeq™II system. The average of 62,201 reads per CD sample was significantly lower than the average of 73,716 reads per control sample. The genera Bacteroides, Eubacterium, Faecalibacterium and Ruminococcus significantly decreased in CD patients as compared to healthy controls. In contrast, the genera Actinomyces and Bifidobacterium significantly increased in CD patients. At the species level, butyrate-producing bacterial species, such as Blautia faecis, Roseburia inulinivorans, Ruminococcus torques, Clostridium lavalense, Bacteroides uniformis and Faecalibacterium prausnitzii were significantly reduced in CD patients as compared to healthy individuals (p < 0.05). These results of 16S rRNA sequencing were confirmed in additional CD patients (n = 68) and in healthy controls (n = 46) using quantitative PCR. The abundance of Roseburia inulinivorans and Ruminococcus torques was significantly lower in C-reactive protein (CRP)-positive CD patients as compared to CRP-negative CD patients (p < 0.05).
Key message: The dysbiosis of CD patients is characterized by reduced abundance of multiple butyrate-producing bacteria species.
© 2016 S. Karger AG, Basel.
Similar articles
-
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464. World J Gastroenterol. 2018. PMID: 29632427 Free PMC article.
-
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.J Gastroenterol. 2018 Jan;53(1):95-106. doi: 10.1007/s00535-017-1384-4. Epub 2017 Aug 29. J Gastroenterol. 2018. PMID: 28852861
-
Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.Inflamm Bowel Dis. 2010 Dec;16(12):2034-42. doi: 10.1002/ibd.21319. Inflamm Bowel Dis. 2010. PMID: 20848492
-
Alteration of the Gut Microbiome in Inflammatory Bowel Disease.Digestion. 2023;104(1):16-23. doi: 10.1159/000525925. Epub 2022 Jul 28. Digestion. 2023. PMID: 35901721 Review.
-
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India.J Gastroenterol. 2016 Jul;51(7):660-71. doi: 10.1007/s00535-016-1193-1. Epub 2016 Mar 19. J Gastroenterol. 2016. PMID: 26994772 Review.
Cited by
-
Beneficial Effect of Faecal Microbiota Transplantation on Mild, Moderate and Severe Dextran Sodium Sulphate-Induced Ulcerative Colitis in a Pseudo Germ-Free Animal Model.Biomedicines. 2023 Dec 22;12(1):43. doi: 10.3390/biomedicines12010043. Biomedicines. 2023. PMID: 38255150 Free PMC article.
-
Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation.Intest Res. 2020 Jul;18(3):325-336. doi: 10.5217/ir.2019.00093. Epub 2020 Jun 23. Intest Res. 2020. PMID: 32564539 Free PMC article.
-
Self-reported sleep quality is associated with gut microbiome composition in young, healthy individuals: a pilot study.Sleep Med. 2020 Sep;73:76-81. doi: 10.1016/j.sleep.2020.04.013. Epub 2020 Apr 23. Sleep Med. 2020. PMID: 32795890 Free PMC article.
-
Modified Montmorillonite Improved Growth Performance of Broilers by Modulating Intestinal Microbiota and Enhancing Intestinal Barriers, Anti-Inflammatory Response, and Antioxidative Capacity.Antioxidants (Basel). 2022 Sep 13;11(9):1799. doi: 10.3390/antiox11091799. Antioxidants (Basel). 2022. PMID: 36139873 Free PMC article.
-
Efficacy and Mechanism of Quercetin in the Treatment of Experimental Colitis Using Network Pharmacology Analysis.Molecules. 2022 Dec 24;28(1):146. doi: 10.3390/molecules28010146. Molecules. 2022. PMID: 36615338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous